NCT06538753|Completed
Silver Leaf During Pregnancy in French Guiana : Use and Impact on Health
Feydarjan
Loading search results
Feydarjan
Sponsor study identifier
observational
332
1 country
1
Study Start
March 21, 2023
Actual (reported)Primary Completion
July 7, 2023
Actual (reported)Study Completion
July 7, 2023
Actual (reported)This is a descriptive, observational, cross-sectional study among women who have given birth in one of French Guiana's maternity hospitals to determine if the use of silver leaf is frequent and could have an impact on pregancy outcomes. This Fey darjan project is an ancillary study of the Nutri Pou Ti'Moun 1 project
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 7, 2023
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 21, 2023
Actual (reported)July 7, 2023
Actual (reported)July 7, 2023
Actual (reported)July 18, 2024
Actual (reported)August 6, 2024
Actual (reported)Prevalence of silver leaf decoction use
To estimate the prevalence of silver leaf decoction use among women who gave birth in one of the French Guiana maternity hospitals assessed by a questionnaire
At inclusion
Description of pregnancy outcomes
At inclusion
Description of immediate post-partum outcomes
At inclusion
Description of delivery pain management method
At inclusion
Use and representations of women using SLDs
At inclusion
Health professionals comprehensions on SLDs use during delivery
At inclusion
Pregnant women delivering in one of the French Guiana maternity hospitals and previously included in study Nutri Pou Ti Moun 1
Centre Hospitalier de Cayenne
Cayenne, 97300, French Guiana
Chang CW, Ko FN, Su MJ, Wu YC, Teng CM. Pharmacological evaluation of ocoteine, isolated from Cassytha filiformis, as an alpha 1-adrenoceptor antagonist in rat thoracic aorta. Jpn J Pharmacol. 1997 Mar;73(3):207-14. doi: 10.1254/jjp.73.207.
Antonio ADS, Aguiar ATC, Dos Santos GRC, Pereira HMG, da Veiga-Junior VF, Wiedemann LSM. Phytochemistry by design: a case study of the chemical composition of Ocotea guianensis optimized extracts focused on untargeted metabolomics analysis. RSC Adv. 2020 Jan 21;10(6):3459-3471. doi: 10.1039/c9ra10436d. eCollection 2020 Jan 16.
Celia BASURKO, MD
Centre Hospitalier de Cayenne
332 participants (actual enrollment reported by the registry).
First Submitted
July 18, 2024
First Posted
August 6, 2024
Study Start
March 21, 2023
Actual (reported)Early Warning Scores in Pregnant Woman
Contact the study team to confirm eligibility.
Antonio AS, Veiga-Junior VF, Wiedemann LSM. Ocotea complex: A metabolomic analysis of a Lauraceae genus. Phytochemistry. 2020 May;173:112314. doi: 10.1016/j.phytochem.2020.112314. Epub 2020 Feb 29.
Guterres Zda R, da Silva AF, Garcez WS, Garcez FR, Fernandes CA, Garcez FR. Mutagenicity and recombinagenicity of Ocotea acutifolia (Lauraceae) aporphinoid alkaloids. Mutat Res. 2013 Sep 18;757(1):91-6. doi: 10.1016/j.mrgentox.2013.07.004. Epub 2013 Jul 24.
Primary Completion
July 7, 2023
Actual (reported)Study Completion
July 7, 2023
Actual (reported)Last Updated
August 6, 2024
Record last verified: 2024-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: